Northland Capmk Lifts Earnings Estimates for Spectral AI

Spectral AI, Inc. (NASDAQ:MDAI - Free Report) - Equities researchers at Northland Capmk boosted their FY2025 EPS estimates for shares of Spectral AI in a note issued to investors on Monday, June 30th. Northland Capmk analyst C. Byrnes now expects that the company will post earnings of ($0.15) per share for the year, up from their previous forecast of ($0.16). The consensus estimate for Spectral AI's current full-year earnings is ($0.48) per share.

MDAI has been the subject of a number of other research reports. Wall Street Zen raised shares of Spectral AI from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. HC Wainwright reaffirmed a "buy" rating and set a $3.50 price objective on shares of Spectral AI in a research report on Wednesday, April 2nd.

Spectral AI Stock Performance

Shares of Spectral AI stock traded up $0.18 during trading on Thursday, reaching $2.71. The company had a trading volume of 718,805 shares, compared to its average volume of 874,662. The company has a market cap of $68.49 million, a price-to-earnings ratio of -5.01 and a beta of 0.90. The firm's fifty day moving average is $1.72 and its 200-day moving average is $1.76. Spectral AI has a fifty-two week low of $0.82 and a fifty-two week high of $3.25.

Institutional Investors Weigh In On Spectral AI

A number of institutional investors have recently modified their holdings of the business. Virtu Financial LLC bought a new position in Spectral AI in the 4th quarter worth about $38,000. Northern Trust Corp bought a new position in Spectral AI in the 4th quarter worth about $44,000. Jane Street Group LLC bought a new position in Spectral AI in the 4th quarter worth about $92,000. Renaissance Technologies LLC bought a new position in Spectral AI in the 4th quarter worth about $272,000. Finally, Avantax Planning Partners Inc. grew its position in Spectral AI by 44.7% in the 4th quarter. Avantax Planning Partners Inc. now owns 231,336 shares of the company's stock worth $655,000 after purchasing an additional 71,484 shares during the last quarter. Institutional investors own 67.08% of the company's stock.

About Spectral AI

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.